Subscribe
|
Contact Us
|
DNAnexus Closes $15 Million Series B
Thursday, October 13, 2011
5:58:00 AM PDT | VentureDeal Staff
Palo Alto, California -- Biotechnology company
DNAnexus
has received $15 million in its second round of institutional venture capital investment.
DNAnexus is creating next-generation DNA sequencing technologies that aims to provide personal genomic identification for better cancer treatments.
TPG Biotech and Google Ventures led the round, which also included SoftTech VC, K9 Ventures, First Round Capital and Felicis Ventures.
The company said it would use the financing to continue product development and hire additional employees.
Email Page
|
Print Page
Loading
Want unlimited access to the
complete database
with thousands of technology companies, VCs and transactions for only $25 per month?
Start your
Free 14 Day Trial
now – no obligation or credit card required.
